相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
Christopher J. Hoimes et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
Paul V. Viscuse et al.
FRONTIERS IN ONCOLOGY (2021)
Preclinical safety profile of disitamab vedotin:a novel anti-HER2 antibody conjugated with MMAE
Jing Jiang et al.
TOXICOLOGY LETTERS (2020)
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial
Luigi Dogliotti et al.
EUROPEAN UROLOGY (2007)
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-Operative Oncology Group
H Linardou et al.
UROLOGY (2004)
分享论文
